The announcement of the results from a Phase 1 trial is a significant event for a pharmaceutical company like Aclaris Therapeutics. However, without the details of the results, it's difficult to predict the impact on the company's stock. The news could be interpreted positively, as the company is making progress in its research, or negatively, if the lack of details suggests the results were not favorable.